PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 17 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 13,002,000 | $11,937,000 | 19.35% |
| Context Capital Management, LLC | 8,175,000 | $7,546,000 | 6.49% |
| Venator Capital Management Ltd. | 2,000,000 | $1,854,000 | 1.27% |
| LINDEN ADVISORS LP | 27,867,000 | $25,654,000 | 0.79% |
| WHITEBOX ADVISORS LLC | 22,181,000 | $20,365,000 | 0.66% |
| Pinnacle Holdings, LLC | 1,640,000 | $1,503,691,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $15,400,000 | 0.20% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,060,000 | $4,670,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $2,908,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,000,000 | $917,000 | 0.02% |